baber/WOPTO huggingface dataset:
Patent EP-2998146-A2 (EP)
Inventor: LEE JUNGGU
IPC: B60K1/00
Filed: 2015-08-25
Abstract: Disclosed herein is a driving module for vehicles including a vehicle driving motor, a case configured to accommodate the vehicle driving motor and a gear device transmitting rotary force of the vehicle driving motor to axles, a vehicle interior air conditioning compressor mounted on the case, and an integrated control module mounted on the case and including a first power conversion device to drive the ve hicle driving motor and a second power conversion device to drive the vehicle interior air conditioning compressor, the first and second power conversion devices being integrated into the integrated control module, thus having a compact and lightweight structure and minimizing the number of parts.
Patent EP-3146048-A2 (EP)
Inventor: AMRANE SAMIR
IPC: C12N15/113
Filed: 2015-05-22
Abstract: The present invention relates to nucleic acid sequences which are fragments of HIV-1 genome. The nucleic acids of the present invention are use as decoys for the treatment of lentivirus infection.In particular, the present invention relates to nucleic acids capable of forming at least one G-quadruplex domain and that are capable of inhibiting the replication of at least one lentivirus, such as HIV-1.
Patent EP-3145307-A2 (EP)
Inventor: MURPHY ANDREW J
IPC: C12N9/00
Filed: 2015-05-18
Abstract: Genetically modified non-human animals expressing human EPO from the animal genome are provided. Also provided are methods for making non-human animals expressing human EPO from the non-human animal genome, and methods for using non-human animals expressing human EPO from the non-human animal genome. These animals and methods find many uses in the art, including, for example, in modeling human erythropoiesis and erythrocyte function; in modeling human pathogen infection of erythrocytes; in in vivo screens for agents that modulate erythropoiesis and/or erythrocyte function, e.g. in a healthy or a diseased state; in <u> in vivo </u> screens for agents that are toxic to erythrocytes or erythrocyte progenitors; in in vivo screens for agents that prevent against, mitigate, or reverse the toxic effects of toxic agents on erythrocytes or erythrocyte progenitors; in in vivo screens of erythrocytes or erythrocyte progenitors from an individual to predict the responsiveness of an individual to a disease therapy.
Patent EP-3179947-A2 (EP)
Title: Environnement de réalité chirurgicale augmentée pour un système chirurgical robotique
Inventor: CARNES TONY
IPC: A61B34/00
Filed: 2015-07-20
Abstract: La présente invention concerne un système chirurgical robotique qui comprend un pupitre de commande configuré pour actionner au moins un bras robotique et au moins un moteur d'entraînement configuré pour recevoir une entrée venant du pupitre de commande et commander le ou les bras robotiques en fonction de l'entrée provenant du pupitre de commande. Un instrument chirurgical est couplé au(x) bras robotiques. L'instrument chirurgical est inséré dans un patient et capture une image d'une région d'intérêt à l'intérieur du patient pendant une intervention chirurgicale. Un dispositif de commande reçoit l'image et applique au moins un filtre de traitement d'image afin d'identifier au moins une propriété non visible d'un objet dans la région d'intérêt. Un écran affiche l'image à l'attention d'un utilisateur.
Patent EP-3173088-A2 (EP)
Title: Fruit extracts
Inventor: O'KENNEDY NIAMH
IPC: A61K36/81
Filed: 2009-11-02
Abstract: Provided are methods of making an extract of fruit of the  Solanaceae  family wherein fruit is processed to optimise the platelet aggregation inhibiting activity of the extract. The methods involve preparing a start mix of homogenised fruit; separating a water soluble fraction from fruit solids; filtration of the water soluble fraction; and concentration of active agents in the filtration permeate The invention also provides fruit extracts manufactured by such methods, and also fruit extracts containing glycosylated phenolic acid or a phenolic ester, or derivatives thereof; a glycosylated flavonoid; and a nucleoside. The extracts of the invention are useful as medicaments for the treatment or prevention of a medical condition characterised by inappropriate platelet aggregation. In particular, the medicaments may be of use in maintaining heart health by reducing platelet aggregation; benefiting the circulation; and/or normalizing or otherwise benefiting blood flow.
Patent EP-3112545-A2 (EP)
Inventor: BRAUN ROGER
IPC: E04B1/86
Filed: 2016-06-29
Abstract: Die Erfindung betrifft ein Akustikpaneel zur Verwendung als Decken- und Wandbelag, aufweisend eine Basisplatte, mindestens umfassend eine Holzwerkstoffplatte mit einer Oberseite und einer Unterseite und einer auf der Oberseite angeordneten Deckschicht, eine an der Unterseite angeordneten Absorbereinheit zum Absorbieren von Raumschall und eine Vielzahl die Basisplatte vollständig durchsetzende Ausnehmungen zum Durchleiten von auf die Oberseite des Paneels treffenden Raumschalls in die Absorbereinheit. Um ein strukturell besonders einfach aufgebautes und kostengünstig herstellbares Akustikpaneel bereitzustellen, mit dem versatzlose und optisch ansprechende Oberflächen ausgebildet werden können, ist vorgesehen, dass an den Längsseiten und/oder Querseiten der Basisplatte zueinander korrespondierende Verriegelungsprofile zum klebstofffreien Verbinden mit weiteren Akustikpaneelen angeordnet sind.
Patent EP-3349781-A2 (EP)
Title: Utilisation de la lysine pour restaurer/augmenter l'activité antibactérienne des antibiotiques inhibée par la présence d'un tensioactif pulmonaire
Inventor: WITTEKIND MICHAEL
IPC: A61P31/04
Filed: 2016-09-16
Abstract: La présente divulgation concerne des procédés permettant de restaurer ou d'augmenter l'activité bactéricide d'un antibiotique dans un organe ou un tissu dans lequel un tensioactif pulmonaire est présent. Plus spécifiquement, la présente divulgation décrit que l'inhibition des antibiotiques par des facteurs environnementaux, tels que la présence d'un tensioactif pulmonaire dans un organe ou un tissu comme l'épithélium respiratoire peut être évitée ou surmontée et que l'efficacité de l'antibiotique dans ce milieu peut être restaurée ou augmentée par co-administration d'un antibiotique et d'une lysine.
Patent EP-3295947-A2 (EP)
Inventor: OH SEI RYANG
IPC: A61K36/575
Filed: 2016-05-13
Abstract: The present invention relates to a pharmaceutical composition comprising any of an extract of  Magnoliae flos , a fraction or an active fraction obtained by fractionation thereof with an organic solvent, and a compound separated therefrom as an active ingredient for preventing and treating chronic obstructive pulmonary disease. It was confirmed that the extract of  Magnoliae flos , the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom inhibits the expression of MUC5AC induced by TNF-α and the promoter activity in human lung cancer mucosal cells (H292), reduces the number of inflammatory cells in the bronchoalveolar lavage fluid of the chronic obstructive pulmonary disease mouse model, inhibits the production of reactive oxygen species, and reduces the cytokines. Therefore, the extract of  Magnoliae flos , the fraction or the active fraction obtained by fractionation thereof with an organic solvent, or the compound separated therefrom can be advantageously used as a pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease.
Patent EP-3223434-A2 (EP)
Inventor: TOGASHI DAISUKE
IPC: H04B1/3827
Filed: 2017-03-21
Abstract: An electronic apparatus capable of reducing SAR and, simultaneously, performing a radio communication in an excellent manner is provided. To that end, an electronic apparatus to be worn on the user's head for use includes lenses positioned in front of the user's eyes when the electronic device is worn on the user's head and an array antenna configured with a plurality of antennas formed on surfaces of the lenses.
Patent EP-3229461-A2 (EP)
Inventor: TAKANASHI HIDEYA
IPC: H04N5/232
Filed: 2017-03-30
Abstract: The accessory apparatus (100) includes an accessory communicator (112) providing a notification channel (RTS), a first data communication channel (DCL) and a second data communication channel (DCL). The accessory controller (111) transmits, in response to receiving a transmission request from an image-capturing apparatus (200) through the notification channel, accessory data to the image-capturing apparatus through the first data communication channel and receives camera data transmitted from the image-capturing apparatus through the second data communication channel. The accessory controller has a function of detecting a camera communication error in the camera data and is configured to, when detecting the camera communication error, transmit accessory error information to the image-capturing apparatus and erase the accessory data stored in an accessory data buffer.
Patent EP-3296437-A2 (EP)
Inventor: GEONKA DIPALI
IPC: D03D15/00
Filed: 2017-09-18
Abstract: An embodiment of the present disclosure is a performance fabric. The performance fabric includes a plurality of warp yarns extending along a warp direction. The warp yarn includes a first warp yarn and a second warp yarn that is directly adjacent to the first warp yarn. The plurality of warp yarns are blended staple warp yarns each of which has cotton fibers and regenerated cellulosic fibers. The performance fabric includes a plurality of weft yarns interwoven with the plurality of warp yarns to define a woven fabric structure. The plurality of weft yarns includes at least one yarn comprising thermoplastic fibers or a blend yarn comprising regenerated cellulosic fibers.
Patent EP-3309814-A2 (EP)
Inventor: NARUSE TATSUO
IPC: H01J37/141
Filed: 2017-09-19
Abstract: There is provided an objective lens capable of reducing the effects of magnetic fields on a sample. The objective lens permits observation of the sample at high resolution. The objective lens (100) includes a first electromagnetic lens (10) and a second electromagnetic lens (20). The first and second lenses (10, 20) produce their respective magnetic fields including components lying along an optical axis (L), and are so arranged that the component of the magnetic field of the first lens (10) lying along the optical axis (L) and the component of the magnetic field of the second lens (20) lying along the optical axis (L) cancel out each other at a sample placement surface (2). The first lens (10) includes an inner polepiece (15) and an outer polepiece (16). Similarly, the second lens (20) includes an inner polepiece (25) and an outer polepiece (26). The inner polepieces (15, 25) have front end portions (15a, 25a), respectively. The outer polepieces (16, 26) have front end portions (16a, 26a), respectively, which jut out toward the optical axis (L). The distances (D1, D4) of the front end portions (16a, 26a) of the outer polepieces (16, 26), respectively, from the sample placement surface (2) are less than the distances (D2, D4) of the front end portions (15a, 25a) of the inner polepieces (15, 25), respectively, from the sample placement surface (2).
Patent EP-3436737-A2 (EP)
Title: Récipient sous pression et procédé de formation d'une couche externe d'un récipient sous pression
Inventor: PERROT ALICE
IPC: B65H54/02
Filed: 2017-03-30
Abstract: L'invention concerne un procédé de formation d'une couche externe autour d'un revêtement ayant une partie cylindrique, afin d'obtenir un récipient sous pression. Le procédé consiste à : fournir une ou plusieurs couches d'enveloppement tangentiel par enveloppement d'un ou de plusieurs premiers faisceaux de fibres avec un premier angle de fibre entre 80 et 100 degrés par rapport à la direction axiale de la partie cylindrique ; et former une ou plusieurs couches tressées par tressage d'un ou de plusieurs seconds faisceaux de fibres avec un second angle de fibre inférieur à 75 degrés par rapport à la direction axiale de la partie cylindrique. La ou les couches d'enveloppement tangentiel et tressées forment ensemble une couche externe autour de la partie cylindrique, de préférence, les couches d'enveloppement tangentiel constituant entre 5 et 30 pour cent en poids de la teneur totale en fibres de la couche externe ; et les couches tressées constituant entre 70 et 95 pour cent en poids de celle-ci.
Patent EP-3460453-A2 (EP)
Inventor: HAN SUNG HO
IPC: G01N21/31
Filed: 2017-02-17
Abstract: The present disclosure discloses a frequency domain (FD)-based multi-wavelength bio-signal analyzing apparatus including: four or more light sources configured to irradiate frequency-modulated light at four or more different discrete wavelengths; at least one light detector configured to detect an output light reflected and introduced from a subject; and a processing circuit connected to the four or more light sources and the at least one light detector and configured to calculate a scattering coefficient and an absorption coefficient at each discrete wavelength based on an output light detected by the at least one light detector and calculate a concentration of a chromophore present in the subject based on the scattering coefficient and the absorption coefficient at each discrete wavelength. Herein, the processing circuit drives at least two of the four or more light sources based on the chromophore present in the subject.
Patent EP-3410066-A2 (EP)
Inventor: KIM STEVEN
IPC: G01C19/72
Filed: 2018-05-17
Abstract: An interface for a hollow core fiber is provided that facilitates the direct pigtailing of the hollow core fiber to a port on an electro-optic device. The interface includes an angled face that attaches to the electronic device at an angle that minimizes optical power loss as light propagates from the electronic device to the hollow core fiber.
Patent EP-3560929-A2 (EP)
Inventor: TAMURA YOSHINORI
IPC: C07D489/08
Filed: 2011-11-11
Abstract: The present invention relates to a process for preparing a compound of the formula (II):
     
wherein R 1b  is a hydroxy-protecting group, R 2  is optionally substituted lower alkyl, and R 3  is optionally substituted lower alkyl, optionally substituted cycloalkyl, substituted or non-substituted aryl or substituted or non-substituted heteroaryl, characterized by reacting a compound of the formula (III):
     
wherein R 1b  and R 2  are the same as defined above, in the presence or absence of an acid with a compound of the formula: R 3 -N=C=O , wherein R 3  is the same as defined above, or with a compound of the formula: R 3 -NH-C(=O)-X, wherein R 3  is the same as defined above and X is a leaving group.
Patent EP-3560966-A2 (EP)
Inventor: JIANG SHENG
IPC: C10N30/02
Filed: 2019-04-23
Abstract: A viscosity index improver comprising a reaction product of (i) an acylated copolymer obtainable by acylating a copolymer of ethylene and one or more C 3 -C 10  alpha-olefins having an Mn of 3,000 to 250,000 g/mol; and (ii) a compound of the formulae (I)-(V):
     
     
     
     
     
wherein R 1 , R 6 , R 8 , R 9 , R 10 , R 12  and R 15  are independently selected from a hydrogen and an optionally substituted linear or branched alkyl or alkenyl group, and R 2 , R 3 , R 4 , and R 5  R 7 , R 11 , R 13 , R 14 , R 16 , and R 17  are independent selected from an optionally substituted linear or branched alkyl or alkenyl group, and a sum of the number of carbon atoms in each compound of the formulae (I)-(V) is from 6 to 31.
Patent EP-3877019-A2 (EP)
Inventor: HOLT ZACHARY
IPC: A61M5/31
Filed: 2019-11-06
Abstract: A catheter system and method of introducing an intravenous catheter into a patient includes a syringe, an access needle, a pliable catheter, and a guidewire. The syringe has a first chamber and a distal syringe end portion, which defines a conduit distally extending to a distal syringe opening such that the conduit fluidly connects the first chamber to the distal syringe opening. The access needle defines a needle lumen longitudinally extending therethrough and is secured relative to the distal syringe end portion. The pliable catheter is releasably secured relative to the access needle. The guidewire distally extends through the conduit toward the distal syringe opening and is configured to selectively move through the conduit, the distal syringe opening, and along the needle lumen to thereby guide movement of the pliable catheter relative to the access needle for introducing the pliable catheter into the patient.
Patent EP-3898697-A2 (EP)
Inventor: BURGER MATTHEW
IPC: A61K39/395
Filed: 2019-12-18
Abstract: This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
Patent EP-3686097-A2 (EP)
Inventor: RASCHE JOHANNES
IPC: B62K7/00
Filed: 2020-01-21
Abstract: Ein Verkleidungselement, das insbesondere aus Partikelschaum hergestellt ist oder Partikelschaum aufweist, besteht insbesondere aus mindestens zwei Verkleidungsteilen (40, 42). Die Verkleidungsteile (40, 42) decken im montierten Zustand ein Oberrohr (16), ein Sattelrohr (18), ein Unterrohr (20), ein Lenkerrohr (22) und/oder ein Tretlagergehäuse (24) ab.
Patent EP-3705849-A2 (EP)
Inventor: VELASTRI MICHELE
IPC: G08G5/00
Filed: 2020-03-05
Abstract: An approach is provided for visualizing risk levels associated with aerial vehicle flights. The approach, for example, involves determining a flight path for an aerial vehicle. The approach also involves calculating at least one risk area along the flight path based on risk-related data associated with the flight path (e.g., data on population density, electromagnetic fields, absence of location signals such as Global Positioning System (GPS) signals, weather, network coverage, aviation related data, etc.). The approach further involves generating a representation of the at least one risk area as a virtual obstacle object and rendering the virtual obstacle object in a user interface of a device in relation to the flight path.
Patent EP-3755053-A2 (EP)
Inventor: WANG YAN
IPC: H04L45/16
Filed: 2013-06-27
Abstract: The present invention discloses a method for controlling handover of user equipment, including: acquiring indication information used for controlling handover of user equipment, where the indication information is used for indicating a cell or base station that can provide a multi-connectivity service to the user equipment; determining, according to the indication information, from the cell or base station that can provide a multi-connectivity service to the user equipment, a target cell or a target base station for handover; and sending a handover request to a base station of the target cell or the target base station, so that the base station of the target cell or the target base station provides a connectivity service to the user equipment. Embodiments of the present invention further provide a corresponding base station, corresponding user equipment, and a corresponding system. By means of the technical solutions of the present invention, user equipment can be accurately handed over to a base station that provides a multi-connectivity service to the user equipment.
Patent EP-3786737-A2 (EP)
Title: Verfahren zur automatisierten einrichtung eines rohlings in einer bearbeitungsmaschine
Inventor: BENZINGER FRANK
IPC: G05B19/4099
Filed: 2020-08-10
Abstract: Die Erfindung betrifft ein Verfahren zur automatisierten Einrichtung eines Rohlings in einer Bearbeitungsmaschine, insbesondere einer Dentalfräsmaschine. Die Dentalfräsmaschine umfasst eine Rechnereinheit (24), eine Werkstückhalterung (10) und eine Bilderfassungseinheit (12) zur optischen Erfassung von Bilddaten eines in der Werkstückhalterung (10) aufgenommenen Rohlings (11). Das erfindungsgemäße Verfahren umfasst die folgenden Schritte:- Fixieren eines Rohlings (11) in der Werkstückhalterung (10),- Erstellen eines Bildes des Rohlings (11) mittels der Bilderfassungseinheit (12),- Unterteilen des Rohlings (11) in einen bereits bearbeiteten Bereich (14) und in einen unbearbeiteten Bereich (15) anhand der erfassten Bilddaten,- Zuordnen einer herzustellenden Werkstückgeometrie (17) dem unbearbeiteten Bereich (15) des Rohlings (11) und- Durchführen der Fräsbearbeitung.
Patent EP-3789431-A2 (EP)
Title: Particles comprising polyamides with in-backbone optical absorbers and related methods
Inventor: FARRUGIA VALERIE M
IPC: B29C64/153
Filed: 2020-09-03
Abstract: A method for producing highly spherical polymer particles comprising a polyamide having an optical absorber in a backbone of the polyamide (IBOA-polyamide) may comprise: mixing a mixture comprising the IBOA-polyamide, a carrier fluid that is immiscible with the IBOA-polyamide, and optionally an emulsion stabilizer at a temperature greater than a melting point or softening temperature of the IBOA-polyamide and at a shear rate sufficiently high to disperse the IBOA-polyamide in the carrier fluid; and cooling the mixture to below the melting point or softening temperature of the IBOA-polyamide to form particles comprising the IBOA-polyamide and the emulsion stabilizer, when present, associated with an outer surface of the particles.
Patent EP-3966437-A2 (EP)
Inventor: BINI ROBERTO
IPC: F01K23/02
Filed: 2020-04-30
Abstract: Cascade organic Rankine cycle plant (100) comprising a hot source (10), at least a first high temperature organic Rankine cycle (110) and a second low temperature organic Rankine cycle (120), said cycles comprising at least one preheater (2, 4, 14), at least one vaporizer (1, 11), at least one turbine (5, 15), at least one condenser (6, 16), wherein the hot source (10) first supplies a vaporizer (1) of the high temperature cycle (110), then the vaporizer (11) of the low temperature cycle (120) and finally it is divided into two flows which supply a first preheater (4) of the high temperature cycle (110) and a preheater (14) of the low temperature cycle (120). The first high-temperature organic Rankine cycle (110) comprises a further vaporizer (7) operating at an intermediate pressure between the vaporizer pressure (1) of the high temperature cycle (110) and the vaporizer pressure (11) of the low temperature cycle (120), said further vaporizer (7) being supplied by a partial flow of the hot source (10) extracted downstream of the first vaporizer (1) and upstream of a second preheater (2) of the same high temperature cycle (110) and said further vaporizer (7) being used to produce vapor of organic fluid at the intermediate pressure to be used in the turbine (5) of the high temperature cycle (110).
Patent EP-4048367-A2 (EP)
Inventor: HARJES DANIEL I
IPC: A61M60/546
Filed: 2020-10-15
Abstract: La présente invention concerne un système d'assistance circulatoire qui comprend une pompe à sang implantable comprenant un boîtier, un rotor servant à pomper le sang d'une entrée à une sortie, un stator et au moins deux des éléments suivants : un capteur de courant, un capteur de position de rotor, un accéléromètre et un capteur de pression. Le dispositif de commande est connecté aux capteurs et comprend un module de traitement de signaux configuré pour recevoir un flux de données en provenance de chacun des capteurs. Le module de traitement de signaux est également configuré pour filtrer les flux de données reçus en provenance de la pluralité de capteurs, déterminer au moins un élément parmi un paramètre de fonctionnement de pompe, une caractéristique cardiaque et un paramètre de commande de pompe sur la base d'au moins deux des flux de données filtrés, et délivrer ledit élément parmi le paramètre de fonctionnement de pompe, la caractéristique cardiaque et le paramètre de commande de pompe à au moins un module parmi le module d'interface d'opérateur et le module de commande de pompe.